Loading stock analysis…
Evidence Synthesis
Last synthesized: 20 Oct 2026, 08:03
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
Gianlife Sees Significant Improvement in Gross Margin and Marginal Operating Leverage, Despite Declining Daily Volume and Close Price.
Gianlife's gross margin accelerated to , up from 12.18%. The company's marginal operating leverage also improved, moving from -25.34% to 12.18%. However, the daily volume decreased to 6082 shares, down from 6812 shares. The close price declined to 4.35 INR, down from 4.54 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 72.79 % | 12.18 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 12.18 % | -25.34 | ▲ |
| REVENUE_GROWTH_YOY | -29.3 % | -70.6 | ▲ |
| PRICE_CHANGE_PERCENT | -4.185 % | — | - |
| DAILY_VOLUME | 6,082 shares | 6,812 | ▼ |
| CLOSE_PRICE | 4.35 INR | 4.54 | ▼ |
Cite this
Source: Samhati evidence synthesis for GIANLIFE (2026-10-20). Observation: Gianlife Sees Significant Improvement in Gross Margin and Marginal Operating Leverage, Despite Declining Daily Volume and Close Price. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/gianlife
Filing step-changes